Non-Interventional Study on the Tolerability and Efficacy of IVIG
Non-Interventional Study on the Tolerability and Efficacy of IVIG
Non-Interventional Study on the Tolerability and Efficacy of octagam® 10%
A Non-Interventional Study on the Tolerability and Efficacy of Octagam 5% or 10% or panzyga.
 Patients with any indication (replacement and immonomodulation) as prescribed by the treating
 physician. Marketed Octagam 5% or 10% or panzyga will be used according to the investigator
 prescription; intravenous (iv) administration.The primary objective is to detect and evaluate
 adverse drug reactions (ADRs) occurring during or after the administration of Octagam or
 panzyga in any indication, age group or treatment regimen, where a causal relationship to the
 administration of Octagam or panzyga is suspected.
Inclusion Criteria:

 -  Any patient who needs to be treated with a product of this class because of his/her
 medical condition and whom the treating physician decides to prescribe Octagam or
 panzyga regularly, may be included.

 Exclusion Criteria:

 -  None